Cetera Investment Advisers’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Buy |
94,277
+18,489
| +24% | +$93.6K | ﹤0.01% | 3006 |
|
|
2025
Q1 | $401K | Buy |
75,788
+13,955
| +23% | +$73.8K | ﹤0.01% | 3033 |
|
|
2024
Q4 | $418K | Buy |
61,833
+13,751
| +29% | +$93K | ﹤0.01% | 2819 |
|
|
2024
Q3 | $317K | Sell |
48,082
-3,107
| -6% | -$20.5K | ﹤0.01% | 3019 |
|
|
2024
Q2 | $384K | Buy |
51,189
+4,896
| +11% | +$36.7K | ﹤0.01% | 2804 |
|
|
2024
Q1 | $462K | Buy |
46,293
+33,521
| +262% | +$334K | ﹤0.01% | 2661 |
|
|
2023
Q4 | $126K | Buy |
+12,772
| New | +$126K | ﹤0.01% | 2119 |
|